{"id":"https://openalex.org/W1671259635","doi":"https://doi.org/10.1080/10826076.2013.765457","title":"REVERSED-PHASE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT IN AN ANALYTICAL QUALITY BY DESIGN FRAMEWORK","display_name":"REVERSED-PHASE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT IN AN ANALYTICAL QUALITY BY DESIGN FRAMEWORK","publication_year":2013,"publication_date":"2013-08-01","ids":{"openalex":"https://openalex.org/W1671259635","doi":"https://doi.org/10.1080/10826076.2013.765457","mag":"1671259635"},"language":"en","primary_location":{"id":"doi:10.1080/10826076.2013.765457","doi":"https://doi.org/10.1080/10826076.2013.765457","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10826076.2013.765457","pdf_url":null,"source":{"id":"https://openalex.org/S123147032","display_name":"Journal of Liquid Chromatography & Related Technologies","issn_l":"1082-6076","issn":["1082-6076","1520-572X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Liquid Chromatography & Related Technologies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024183294","display_name":"George L. Reid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George L. Reid","raw_affiliation_strings":["a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078819228","display_name":"Guilong Charles Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guilong Cheng","raw_affiliation_strings":["a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David T. Fortin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David T. Fortin","raw_affiliation_strings":["a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007181560","display_name":"Jeffrey W. Harwood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Harwood","raw_affiliation_strings":["a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111478455","display_name":"James E. Morgado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James E. Morgado","raw_affiliation_strings":["a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100370338","display_name":"Jian Wang","orcid":"https://orcid.org/0000-0001-5870-851X","observed_orcids":["https://orcid.org/0000-0001-5870-851X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jian Wang","raw_affiliation_strings":["a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":null,"display_name":"Gang Xue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gang Xue","raw_affiliation_strings":["a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Analytical Research and Development, Pfizer Worldwide Research and Development ,  Groton ,  Connecticut ,  USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Analytical Research and Development, Pfizer Worldwide Research and Development , Groton , Connecticut , USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5024183294"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":null,"apc_paid":null,"fwci":1.7061,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.80217907,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"36","issue":"18","first_page":"2612","last_page":"2638"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/analytical-quality-by-design","display_name":"analytical quality by design","score":0.8529999852180481},{"id":"https://openalex.org/keywords/reversed-phase-liquid-chromatography","display_name":"reversed-phase liquid chromatography","score":0.8090000152587891},{"id":"https://openalex.org/keywords/method-development","display_name":"method development","score":0.9010000228881836},{"id":"https://openalex.org/keywords/stability-indicating-method","display_name":"stability-indicating assay","score":0.890999972820282},{"id":"https://openalex.org/keywords/risk-assessment","display_name":"risk assessment","score":0.7850000262260437},{"id":"https://openalex.org/keywords/experimental-design","display_name":"experimental design","score":0.9980000257492065},{"id":"https://openalex.org/keywords/method-operable-design-region","display_name":"method operable design region","score":0.9769999980926514},{"id":"https://openalex.org/keywords/methodological-robustness","display_name":"method robustness","score":0.6570000052452087},{"id":"https://openalex.org/keywords/immediate-release-formulation","display_name":"immediate-release formulation","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.7415943145751953},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7373934984207153},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.7246299982070923},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6412214040756226},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.4637696146965027},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.45470601320266724},{"id":"https://openalex.org/C2988729646","wikidata":"https://www.wikidata.org/wiki/Q838129","display_name":"Process development","level":2,"score":0.43242591619491577},{"id":"https://openalex.org/C45188465","wikidata":"https://www.wikidata.org/wiki/Q645497","display_name":"Reversed-phase chromatography","level":3,"score":0.4172515273094177},{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.298117458820343},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.29003578424453735},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.10865631699562073},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.0},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1080/10826076.2013.765457","doi":"https://doi.org/10.1080/10826076.2013.765457","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10826076.2013.765457","pdf_url":null,"source":{"id":"https://openalex.org/S123147032","display_name":"Journal of Liquid Chromatography & Related Technologies","issn_l":"1082-6076","issn":["1082-6076","1520-572X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Liquid Chromatography & Related Technologies","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W5237872","https://openalex.org/W49519407","https://openalex.org/W83204119","https://openalex.org/W1484962307","https://openalex.org/W1505346453","https://openalex.org/W1599377930","https://openalex.org/W2026298927","https://openalex.org/W2042597698","https://openalex.org/W2045932532","https://openalex.org/W2053884177","https://openalex.org/W2062593306","https://openalex.org/W2068818018","https://openalex.org/W2080203675","https://openalex.org/W2104038999","https://openalex.org/W2111054259","https://openalex.org/W2127799943","https://openalex.org/W2200305029","https://openalex.org/W2298016747","https://openalex.org/W2330635582","https://openalex.org/W2470431263","https://openalex.org/W2476181870","https://openalex.org/W2497735451","https://openalex.org/W2928034868"],"related_works":["https://openalex.org/W4407848240","https://openalex.org/W3127007275","https://openalex.org/W7164019982","https://openalex.org/W7223467431","https://openalex.org/W7153184393","https://openalex.org/W7208813393","https://openalex.org/W7166827334","https://openalex.org/W2968248303","https://openalex.org/W7167883871","https://openalex.org/W7137074580"],"abstract_inverted_index":{"The":[0,23,70],"Analytical":[1],"Quality":[2],"by":[3],"Design":[4],"(AQbD)":[5],"concept":[6],"is":[7,26],"demonstrated":[8,29],"in":[9],"the":[10,54,68,76,86,108,112,116,126],"development":[11,38,77],"of":[12,48,53,72,78,88,128],"a":[13,31,58],"stability-indicating":[14],"HPLC":[15],"method":[16,37,59],"for":[17,67],"an":[18],"immediate":[19],"release":[20],"dosage":[21],"form.":[22],"AQbD":[24,73,117],"workflow":[25],"discussed":[27],"and":[28,51,64,91,94,105,119],"with":[30],"systematic":[32,89],"three":[33],"stage":[34],"liquid":[35],"chromatograph":[36],"(wave":[39],"1":[40],"through":[41],"wave":[42],"3),":[43],"risk":[44],"assessment":[45,52],"(RA),":[46],"design":[47,61],"experiments":[49],"(DOEs),":[50],"data":[55],"to":[56,82,111],"provide":[57],"operable":[60],"region":[62],"(MODR)":[63],"center":[65],"point":[66],"method.":[69],"use":[71],"workflows":[74],"streamlines":[75],"methods":[79,97,100],"as":[80],"compared":[81],"traditional":[83],"approaches.":[84],"With":[85],"addition":[87],"RAs":[90],"DOEs,":[92],"robust":[93],"rugged":[95],"analytical":[96],"result.":[98],"These":[99],"will":[101],"have":[102],"fewer":[103],"issues":[104],"failures":[106],"throughout":[107],"lifecycle":[109],"due":[110],"knowledge":[113],"gained":[114],"via":[115],"process":[118],"defining":[120],"chromatographic":[121],"set":[122],"points":[123],"away":[124],"from":[125],"edges":[127],"failure.":[129]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}